Celebrating our journey: INCATE launches first report (2021–2024)

The INCATE Management team is happy to announce the release of INCATE’s first report, covering our work from 2021 to the end of 2024. This milestone provides a comprehensive overview of who we are, how we work, and the ventures we support in the fight against infectious diseases.
A look back at our journey
Since our inception, INCATE has been dedicated to bridging the gap between academia and industry. Our mission is to accelerate the translation of groundbreaking scientific research into real-world solutions, enabling early-stage ventures to grow and thrive. This report captures the full breadth of our activities — from scouting promising projects and providing hands-on support to guiding portfolio ventures toward key milestones.
Inside the report
How INCATE works: Our unique approach to venture support and collaboration.
Our portfolio: A showcase of the innovative projects and startups we’ve supported over the past four years.
Impact highlights: Key achievements and milestones that demonstrate the progress made in translating research into solutions that address global health challenges.
Why it matters
The launch of this report is not just a reflection of what we’ve accomplished, it’s also a celebration of the partnerships, collaborations, and bold ideas that drive INCATE’s mission forward. By sharing our journey, we aim to inspire further innovation in anti-infective research and encourage new collaborations to tackle pressing global health challenges.
Read the full report: INCATE_Report_2021-2024
We look forward to the next chapter of our journey, continuing to support pioneering innovations against infectious diseases and transforming it into real impact.

